APUS Stock Analysis: Buy, Sell, or Hold?
APUS - Apimeds Pharmaceuticals US, Inc.
$0.74
0.02 (2.36%)
▲
5d:
-14.3%
30d:
-42.87%
90d:
-45.0%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 18, 2026
Get Alerted When APUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: APUS is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: APUS is down 14.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: APUS is currently trading at $0.74, which is considered oversold relative to its 30-day fair value range of $0.79 to $1.23.
Technical Outlook: Technically, APUS is in a downtrend. Immediate support is located at $0.68, while resistance sits at $1.09.
Market Sentiment: APUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APUS is in a downtrend. Immediate support is located at $0.68, while resistance sits at $1.09.
Market Sentiment: APUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.79 -
$1.23
Company Quality Score
46/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
88.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- WARNING: Recommendation downgraded due to -14.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.79 -
$1.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.68
Resistance Level
$1.09
Current Trend
Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 14, 2026 2:30 AM ET
Data refreshes hourly during market hours. Next update: 3:30 AM
Data refreshes hourly during market hours. Next update: 3:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APUS showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 51 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |